Recognizing When It Is Time to Treat
September 19, 2024
It is critical to be aware of the signs and symptoms that may indicate there is a need to begin treatment.
It is critical to be aware of the signs and symptoms that may indicate there is a need to begin treatment.
Most people who have been diagnosed with CLL or SLL have no symptoms initially and are usually advised that no treatment is necessary upon diagnosis
Therapeutic options that include Time Off Treatment, also referred to as Time Off Therapy, Fixed Duration Therapy, or Limited Duration Therapy, or Time-Limited Therapy, have multiple advantages for patients, but may not be the best fit for everyone. Listen to Dr. Catherine Coombs and Dr. Brian Koffman discuss what it means to take “time off treatment.” Watch the video, then test your knowledge with a brief quiz!
Knowledge Test – Time Off Treatment – CLL Society
Join the CLL Society and Nurse Practitioner Laura Zitella, who will discuss the timing of CLL treatment and the various factors to consider when navigating your disease journey.
At the annual meeting of the American Society of Hematology (ASH) 2021, our own Dr. Brian Koffman, interviewed Dr. Stephan Stilgenbauer, Professor of Medicine at the Comprehensive Cancer Center at Ulm University in Germany. They discussed the latest results from the GAIA (CLL13) trial, which compared rates of measurable residual disease (MRD) with the different treatments.
Our own Dr. Koffman is quoted in his local paper, the LA Times, in this article: This Treatment Can Protect Vulnerable People From COVID. But Many Don’t Know About It.
The team at Dana-Farber Cancer Institute is testing whether the combination of duvelisib (Copiktra™) and venetoclax (Venclexta®) will lead to deep remissions that would allow for oral only therapy of one year duration. Learn more about this ongoing Phase I/II clinical trial.
Join CLL Society and Dr. Deborah Stephens to learn how a comprehensive approach to well-being can complement your CLL care.
© 2025 CLL Society. All Rights Reserved.
Legal | Privacy Policy | Corporate Giving Policy
Terms & Conditions | Report a Bug | Site Design
CLL Society Inc. is a patient–centric, physician–curated nonprofit organization focused on patient education, support, and research. Dedicated to addressing the unmet needs of the chronic lymphocytic leukemia (CLL) and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research, and educate providers and patients.
CLL Society is a registered 501(c)(3) tax-exempt nonprofit organization. All donations are tax-deductible to the greatest extent as allowed under federal law. CLL Society’s tax ID number is 46-4131354.
1454 Melrose Avenue, Ste. 1-247
Chula Vista, CA 91911